New hope for rare hunger disorder: 12-Month drug trial launches
NCT ID NCT07197034
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study tests whether a daily medication called ARD-101 can safely reduce the intense, constant hunger (hyperphagia) that people with Prader-Willi syndrome experience. About 90 participants who completed a prior study will take the drug for up to 12 months. Researchers will track side effects and changes in hunger-related behaviors using caregiver questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPHAGIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
Suwon, 16499, South Korea
-
Alberta Children's Hospital Research Institute
Calgary, Alberta, T3B 6A8, Canada
-
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611-2991, United States
-
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
-
Children's Hospital Colorado
Denver, Colorado, 80045-7106, United States
-
Children's Hospital at London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
Children's Hospital of Orange Country
Orange, California, 92868, United States
-
Children's of Alabama
Birmingham, Alabama, 35233-1711, United States
-
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30322-1047, United States
-
Fulborn Hospital
Cambridge, CB21 5EF, United Kingdom
-
Inha University Hospital
Incheon, 22332, South Korea
-
Leicester Royal Infirmary
Leicester, LE1 5WW, United Kingdom
-
Maimonides Medical Center
Brooklyn, New York, 11219-2918, United States
-
NYU Langone Children's Ambulatory Care Center
Mineola, New York, 11501-4077, United States
-
Nemours Children's Clinic Wilmington
Wilmington, Delaware, 19803-3607, United States
-
Queensland Children's Hospital
South Brisbane, Queensland, 4101, Australia
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
Royal Hospital for Children (Glasgow) - PPDS - PIN
Glasgow, G51 4TF, United Kingdom
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
Stanford Children's Health Specialty Services
Palo Alto, California, 94304, United States
-
Stollery Children's Hospital
Edmonton, Alberta, Canada
-
The Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
-
The Johns Hopkins Hospital
Baltimore, Maryland, 21287-0005, United States
-
The Royal London Hospital
London, E1 1BB, United Kingdom
-
UF Shands Children's Hospital
Gainesville, Florida, 32610-3008, United States
-
University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota, 55102, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-0005, United States
Conditions
Explore the condition pages connected to this study.